CDKN2B and cervical carcinoma: Researchers have demonstrated the role of CDKN2B‐AS in cervical cancer through in vivo experiments, including tumor growth, apoptosis inhibition, and senescence inhibition, and CDKN2B‐AS1 knockdown can inhibit the above activities.29